Samasta Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -66.26%
- Profit Growth 97.95%
- Ebitda 164.92%
- Net Worth 61.53%
- Total Assets -91.31%
About Samasta Life Science
Samasta Life Science Private Limited (SLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 February 2016 (Eight years and 11 months 13 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Service Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mangesh Wawge, Ujwal Patil, Milind Bhole, and One other member serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01403PN2016PTC158509
-
Company No.
158509
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Feb 2016
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Samasta Life Science?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikramsinha Deshmukh
|
Director | 18-Feb-2016 | Current |
|
Mangesh Wawge
|
Director | 18-Feb-2016 | Current |
|
Ujwal Patil
|
Director | 18-Feb-2016 | Current |
|
Milind Bhole
|
Director | 18-Feb-2016 | Current |
Financial Performance of Samasta Life Science.
Samasta Life Science Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 66.26% decrease. The company also saw a substantial improvement in profitability, with a 97.95% increase in profit. The company's net worth Soared by an impressive increase of 61.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Samasta Life Science?
In 2017, Samasta Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Satara Maha Farmer Producer Company LimitedVikramsinha Deshmukh is a mutual person
-
Rui Farmers Producer Company Limited
Vikramsinha Deshmukh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Samasta Life Science?
Unlock and access historical data on people associated with Samasta Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samasta Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samasta Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.